Zomedica Pharmaceuticals Corp (ZOM)
$0.17
0.01 (5.75%)
ZOM Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
170.22M
PE Ratio
-4.57
EPS
-0.038
Volume (Avg. Vol.)
12.77M
Day's Range
$0.17 - $0.19
52-Week Range
$0.12 - $0.25
Dividend & Yield
N/A (N/A)
ZOM Stock Predictions, Articles, and Zomedica Pharmaceuticals Corp News
Zomedica Is Surprisingly Cheap Even as Commercialization Commences
ZOM stock has spiked sharply this year, but a recent price pullback could signal an ideal entry point for pet care market investors.
Zomedica’s Risks Are Too Big to Ignore
You may like ZOM stock as a pet lover, but not for its fundamentals, nor its valuation until it starts having credible financial results.
Zomedica’s High Share Count Creates Challenges for ZOM Stock
Zomedica has promising growth potential, but its high share count makes ZOM stock a risky investment. Here's what investors should know.
Zomedica Stock Will Be Worth The Risk After Another Drop
Another pullback in ZOM stock will put this long-term speculative play's odds in your favor if its Truforma product catches on.
Right-Priced Zomedica Could Be an Investor’s Best Friend
The skeptics might misinterpret the company's first-quarter revenue data, but a deeper dive should uncover reasons to hold on to ZOM stock.
Bets on Zomedica’s In-Office Vet Test Could Payoff or Bust by Year-End
Zomedica's Truforma machine has entered the vet equipment market, which is consolidating rapidly. That means results on whether this can work should come quickly for ZOM stock investors.
Is Zomedica Making a Change For the Better?
ZOM stock trades below $1 as investors wait to see if recent changes to the company's business model along with potential acquisitions can be a catalyst for revenue.
Zomedica Stock Can Return to a Dollar If It Focuses on Just One Thing
Zomedica is testing its support levels at current prices. What does the maker of diagnostic equipment need to do to get ZOM stock back to $1?
Zomedica Stock Is At Serious Risk Unless Bulls Commit
ZOM stock makes for a better trading vehicle than an investment in spite of their noble effort to heal. It needs to hold recent lows or else.
Why Zomedica Doesn’t Need Reddit
Zomedica has lost the fast money crowd, but what remains could be a stronger longer-term play in ZOM stock.
Zomedica Stock Will Burn You as High-Growth Stocks Start to Flag
The bull market has certainly made new investors look like geniuses, as usual. But now is the true test and ZOM stock isn't likely to pass.
Zomedica Stock Is Clearly Going to Keep Moving in the Wrong Direction
The share price of the Ann Arbor, Michigan-based animal health company has now gone from a pullback and into a steep decline. Since March 15th, ZOM stock has fallen 68% and is now below the $1 threshold at just $0.79 per share. Given the precarious situation, investors should steer clear of this security for now.
Zomedica Is Now a Low-Probability Gamble
ZOM stock attracts plenty of attention for its underlying pet care business and its wild potential but this game may be over.
Zomedica Stock Is Another Hyped-Up Reddit Play That Can’t Escape Reality
Zomedica has potential in a niche business. But the price of ZOM stock does not yet reflect that. This will change as day traders move on.
Why Zomedica Stock Isn’t Worth Buying Right Now
If Truforma truly is a game-changer, there’s hope the company could grab part of a potential $10.5 billion animal diagnostics market.
Zomedica: After a Wild Winter, It’s Back to Business
While ZOM stock has been highly volatile, the business is progressing. The Truforma platform has launched and we'll start seeing revenue figures soon.
5 Reddit Penny Stocks Seeing the Most Chatter Tuesday
We're diving back into the world of penny stocks again today as we look at those that are getting the most discussion over on Reddit.
As Zomedica Stock Loses Altitude, Is It Cheap Enough for a Buy Today?
The music appears to be slowing for retail favorite ZOM stock, so the question is, will the volume get turned up, or will the music stop?
